Bone Defects Clinical Trial
Official title:
CALCIUM PHOSPHATE CEMENT AS BONE VOID FILLER - a Prospective Cohort Study in Patients Indicated for Long Bone and Extremity Surgery
NCT number | NCT04645186 |
Other study ID # | 2019.04 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 5, 2020 |
Est. completion date | June 1, 2023 |
This is an observational, prospective, non-randomised, post market clinical follow-up study to compile clinical data on performance and safety of the synthetic bone graft substitute and to assess that the performance and safety of the device are maintained until the reaching of its intended use in a commercial clinical setting in long bone and extremity defects.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | June 1, 2023 |
Est. primary completion date | June 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients requiring bone grafting after post-traumatic or surgically created bone defects afflicting the long bones and extremities. - Give written informed consent to participate in the study and be willing to comply with the protocol requirements. - Able to verbalize and differentiate regarding the location and intensity of pain. - Physical and mental availability to meet the clinical and radiographic follow-up schedule. Exclusion Criteria: - Serious infection within two months before surgery. - Active malignancy, Cellulitis, Osteomyelitis, Osteomyelitis, Bone metastasis, Other bone metabolic diseases. - Primary bone tumors and contraindications in performing an X-ray or CTscan. - Women of childbearing potential who are, or plan to become, pregnant during the time of the study. - The subject is unable or not willing to complete follow-up visits and examination for the duration of the study. |
Country | Name | City | State |
---|---|---|---|
Portugal | Hospital Lusíadas Lisboa | Lisboa |
Lead Sponsor | Collaborator |
---|---|
Bioceramed | Universidade Nova de Lisboa |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Radiological healing | Bone healing observable by x-ray/CT-scan. Assessment of trabecular defects: modified Neer classification. Assessment of cortical defects: modified RUST. | 3 months | |
Primary | Radiological healing | Bone healing observable by x-ray/CT-scan. Assessment of trabecular defects: modified Neer classification. Assessment of cortical defects: modified RUST. | 6 months | |
Primary | Radiological healing | Bone healing observable by x-ray/CT-scan. Assessment of trabecular defects: modified Neer classification. Assessment of cortical defects: modified RUST. | 9 months | |
Primary | Radiological healing | Bone healing observable by x-ray/CT-scan. Assessment of trabecular defects: modified Neer classification. Assessment of cortical defects: modified RUST. | 12 months | |
Primary | Radiological healing | Bone healing observable by x-ray/CT-scan. Assessment of trabecular defects: modified Neer classification. Assessment of cortical defects: modified RUST. | 18 months | |
Primary | Radiological healing | Bone healing observable by x-ray/CT-scan. Assessment of trabecular defects: modified Neer classification. Assessment of cortical defects: modified RUST. | 24 months | |
Secondary | Number and description of any adverse event during the follow-up | Record and description of any adverse event during the follow-up that reflects the safety of the bone graft substitute. | 3 months | |
Secondary | Number and description of any adverse event during the follow-up | Record and description of any adverse event during the follow-up that reflects the safety of the bone graft substitute. | 6 months | |
Secondary | Number and description of any adverse event during the follow-up | Record and description of any adverse event during the follow-up that reflects the safety of the bone graft substitute. | 9 months | |
Secondary | Number and description of any adverse event during the follow-up | Record and description of any adverse event during the follow-up that reflects the safety of the bone graft substitute. | 12 months | |
Secondary | Number and description of any adverse event during the follow-up | Record and description of any adverse event during the follow-up that reflects the safety of the bone graft substitute. | 18 months | |
Secondary | Number and description of any adverse event during the follow-up | Record and description of any adverse event during the follow-up that reflects the safety of the bone graft substitute. | 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04520087 -
Clinical and Radiographic Assessment After Surgical Treatment of Anterior Shoulder Dislocation
|
N/A | |
Recruiting |
NCT04644536 -
Retrospective Collection of Safety and Performance Data
|
||
Active, not recruiting |
NCT03103295 -
3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects
|
Phase 1/Phase 2 | |
Recruiting |
NCT06269354 -
Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology
|